Page 39 - Influenza Report
P. 39

References   39


                           11059-63. Epub 2005 Jul 26. Abstract: http://amedeo.com/lit.php?id=16046546 – Full text at
                           http://www.pnas.org/cgi/content/full/102/31/11059
                           93.  Osterholm MT. Preparing for the next pandemic. N Engl J Med 2005; 352: 1839-42. Full
                           text at http://content.nejm.org/cgi/content/full/352/18/1839
                           94.  Palese P. Making better influenza virus vaccines? Emerg Infect Dis 2006. Available from
                           http://www.cdc.gov/ncidod/EID/vol12no01/05-1043.htm
                           95.  Peiris JS, Yu WC, Leung CW, et al. Re-emergence of fatal human influenza A subtype
                           H5N1 disease. Lancet 2004; 363: 617-9. Abstract: http://amedeo.com/lit.php?id=14987888
                           96.  Perkins LE, Swayne DE. Pathogenicity of a Hong Kong-origin H5N1 highly pathogenic
                           avian influenza virus for emus, geese, ducks, and pigeons. Avian Dis 2002; 46: 53-63.
                           Abstract: http://amedeo.com/lit.php?id=11924603
                           97.  Peters PH Jr, Gravenstein S, Norwood P, et al. Long-term use of oseltamivir for the
                           prophylaxis of influenza in a vaccinated frail older population. J Am Geriatr Soc 2001; 49: 1025-
                           31. Abstract: http://amedeo.com/lit.php?id=11555062
                           98.  Poole P, Chacko E, Wood-Baker R, Cates C. Influenza vaccine for patients with chronic
                           obstructive pulmonary disease. Cochrane Database Syst Rev 2006. Abstract:
                           http://amedeo.com/lit.php?id=16437444
                           99.  ProMED 20060211.0463. Avian influenza, human  Worldwide (02); Demographics of
                           human avian influenza. Archive number 20060211.0463. Available at
                           http://www.promedmail.org/
                           100. ProMED 20060216.0512. Avian Influenza, human: Genetic risk? Promed number
                           20060216.0512. Accessed on 17 February 2006 – Available at http://www.promedmail.org/
                           101. ProMED 20060224.0603. South Korea - asymptomatic human infection. Promed number
                           20060224.0603. Accessed on 25 February 2006 – Available at http://www.promedmail.org/
                           102. ProMED 20060322.0893. Avian Influenza's Human-attack Pathway Revealed. Promed
                           number 20060322.0893. Accessed on 23 March 2006 – Available at
                           http://www.promedmail.org/
                           103. Reid AH, Fanning TG, Hultin JV, Taubenberger JK. Origin and evolution of the 1918
                           "Spanish" influenza virus hemagglutinin gene. Proc Natl Acad Sci U S A 1999; 96: 1651-6.
                           Abstract: http://amedeo.com/lit.php?id=9990079 – Full text at
                           http://www.pnas.org/cgi/content/full/96/4/1651
                           104. Reyes-Terán. Pandemic Preparedness. In: Influenza Report. Kamps BS, Hoffmann C,
                           Preiser W. Flying Publisher, Wuppertal, 2006a. – Full text at
                           http://www.influenzareport.com/ir/pp.htm
                           105. Rimmelzwaan GF, van Riel D, Baars M, et al. Influenza A Virus (H5N1) Infection in Cats
                           Causes Systemic Disease with Potential Novel Routes of Virus Spread within and between
                           Hosts. Am J Pathol 2006; 168: 176-83. Abstract: http://amedeo.com/lit.php?id=16400021
                           106. Salomon R, Franks J, Govorkova EA, et al. The polymerase complex genes contribute to
                           the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04. J Exp Med
                           2006; Abstract: http://amedeo.com/lit.php?id=16533883
                           107. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al. Guillain-Barre syndrome following
                           vaccination in the National Influenza Immunization Program, United States, 1976--1977. Am J
                           Epidemiol 1979; 110: 105-23. Abstract: http://amedeo.com/lit.php?id=463869
                           108. Seo SH, Hoffmann E, Webster RG. Lethal H5N1 influenza viruses escape host anti-viral
                           cytokine responses. Nat Med 2002; 8: 950-4. Epub 2002 Aug 26. Abstract:
                           http://amedeo.com/lit.php?id=12195436
                           109. Shortridge KF. Pandemic influenza: a zoonosis? Semin Respir Infect 1992; 7: 11-25.
                           Abstract: http://amedeo.com/lit.php?id=1609163
                           110. Shortridge KF. Pandemic influenza: a zoonosis? Semin Respir Infect 1992; 7: 11-25.
                           Abstract: http://amedeo.com/lit.php?id=1609163
                           111. Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic
                           versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 1998;
                           178: 53-60. Abstract: http://amedeo.com/lit.php?id=9652423 – Full text at
                           http://www.journals.uchicago.edu/cgi-bin/resolve?JIDv178p53PDF
   34   35   36   37   38   39   40   41   42   43   44